percept™ non-invasive prenatal test includes assessment of all the chromosomes for identifying pregnancies at increased chance of having a chromosome condition, making it Australia's most advanced NIPT.
Maternal serum screening is a blood test available to pregnant women who want to know their chance of having a baby with a chromosome condition, such as Down syndrome. Serum screening can also provide additional information about pregnancy health, such as the risk of developing early-onset pre-eclampsia.
Newborn bloodspot screening is an extremely successful public health program which identifies babies that may have rare but significant medical conditions.
Clinical genomic sequencing is a powerful test that can help identify the cause of health and developmental problems. In many cases, clinical exome sequencing or whole genome sequencing (WGS) is used to seek answers for patients where other testing has failed to find a cause of their health problems.
Disorders/Differences of Sex Differentiation (DSD) are conditions where the development of chromosomal, anatomical or gonadal sex is atypical. DSD covers a wide spectrum of disorders such as hypospadias (misplacement of the urethral opening on the penis), premature ovarian insufficiency and complete sex reversal (where the physical sex does not match the genetic sex of an individual).
The usefulness of genetic testing for degenerative neurogenetic conditions depends on the condition. While the genetic basis of some neurological conditions is well understood, the basis of others is not. Some of the more common neurogenetic conditions, such as Alzheimer disease or Parkinson disease, have subsets with a clear genetic cause, while the cause of other cases is unknown.
Identification of genetic causes of cardiac disorders can be lifesaving. Establishing a genetic cause for such conditions can affect further patient testing, management and surveillance. This information can also be important for immediate family members, who may be at risk of developing heart problems.
Spinal Muscular Atrophy Carrier Screening
This test is a genetic screen to identify if you are a carrier of spinal muscular atrophy.
You must have a completed doctors request form to order this test online.
The cost of this test is AUD$220.00. No Medicare rebate available.
Spinal muscular atrophy carrier screening is available as a single test to order and pay online.
Cystic Fibrosis Carrier Screening & Diagnostic
This test is a genetic screen to identify if you are a carrier of cystic fibrosis and is available to order and pay online.
You must have a completed doctors request form to order this test.
The cost of this test is AUD$212.50.
Patients may be eligible for a Medicare rebate, if:
Choose VCGS for comprehensive genetic testing and support services for a large range of single gene disorders including cystic fibrosis, fragile X syndrome, ataxias and hearing loss.